Back
Janux Therapeutics Quote, Financials, Valuation and Earnings
Sell
37
JANX
Janux Therapeutics
Last Price:
47.15
Seasonality Move:
8.69%
7 Day Trial
ALL ACCESS PASS
$
7
Janux Therapeutics Price Quote
$47.15
-0.36 (-0.76%)
(Updated: May 17, 2024 at 2:35 PM ET)
Janux Therapeutics Key Stats
Sell
37
Janux Therapeutics (JANX)
is a Sell
Day range:
$46.57 - $48.25
52-week range:
$5.65 - $65.60
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
298.78
P/B ratio:
3.76%
Volume:
680.5K
Avg. volume:
983.8K
1-year change:
312.06%
Market cap:
$2.5B
Revenue:
$8.1M
EPS:
$-1.21
How Much Does Janux Therapeutics Make?
-
How Much Are Janux Therapeutics's Sales Annually?
JANX Revenues are $8.1M -
How Much Profit Does Janux Therapeutics's Make A Year?
JANX net income is -$58.3M
Is Janux Therapeutics Growing As A Company?
-
What Is Janux Therapeutics's Growth Rate Quarterly?
Quarterly YoY revenue growth is -0.39% -
What Is Janux Therapeutics's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0%
Janux Therapeutics Stock Price Performance
-
Did Janux Therapeutics Stock Go Up Last Month?
Janux Therapeutics share price went down by -6.01% last month -
Did JANX's Share Price Rise Over The Last Year?
JANX share price rose by 312.06% over the past 1 year
What Is Janux Therapeutics 52-Week High & Low?
-
What Is Janux Therapeutics’s 52-Week High Share Price?
Janux Therapeutics has traded as high as $65.60 over the past 52 weeks -
What Is Janux Therapeutics’s 52-Week Low Share Price?
Janux Therapeutics has traded as low as $5.65 over the past 52 weeks
Janux Therapeutics Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy Janux Therapeutics?
-
How Much Debt Does Janux Therapeutics Have?
Total long term debt quarterly is $0 -
How Much Cash Does Janux Therapeutics Have?
Cash and short term investments quarterly total is $651.8M -
What Is Janux Therapeutics’s Book Value Per Share?
Book value per share is 12.65
Is Janux Therapeutics Cash Flow Positive?
-
What Is JANX Cash Flow From Operations?
Cash flow from operations (TTM) is -$51.5M -
What Is Janux Therapeutics’s Cash Flow From Financing?
Cash flow from financing (TTM) is $380.1M -
What Is Janux Therapeutics’s Cash Flow From Investing?
Cash flow from investing (TTM) is -$146.2M
Janux Therapeutics Return On Invested Capital
-
Is Management Doing A Good Job?
JANX return on invested capital is -14.18% -
What Is Janux Therapeutics Return On Assets?
ROA measures how assets are converting to revenues and is -12.93% -
What Is JANX Return On Equity?
ROE is a measure of profitability and is -14.18%
Janux Therapeutics Earnings Date & Stock Price
-
What Is Janux Therapeutics's Stock Price Today?
A single share of JANX can be purchased today for 47.51 -
What Is Janux Therapeutics’s Stock Symbol?
Janux Therapeutics trades on the nasdaq under the ticker symbol: JANX -
When Is Janux Therapeutics’s Next Earnings Date?
The next quarterly earnings date for Janux Therapeutics is scheduled on August 8, 2024 -
When Is JANX's next ex-dividend date?
Janux Therapeutics's next ex-dividend date is May 17, 2024 -
How To Buy Janux Therapeutics Stock?
You can buy Janux Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Janux Therapeutics Competitors
-
Who Are Janux Therapeutics's Competitors?
Below is a list of companies who compete with Janux Therapeutics or are related in some way:
Janux Therapeutics Dividend Yield
Data Unavailable
Janux Therapeutics Analyst Estimates
| YoY Growth | Past Surprise | |
|---|---|---|
| EPS: | 0% | 9.09% |
| Revenue: | -38.87% | 23.01% |
Analyst Recommendations
| Buy Recommendations: | 8 |
|---|---|
| Hold Recommendations: | 0 |
| Sell Recommendations: | 0 |
| Price Target: | 63.57 |
| Upside from Last Price: | 33.81% |